Conclusion We conclude that addition of ALC therapy is superior to metformin plus pioglitazone in ameliorating insulin resistance, polycystic ovaries, menstrual irregularities, and hypoadiponectinemia in women with PCOS
The weight loss was also accompanied by significant reductions in waist circumference, known to raise the risk of cardiovascular disease and other weight-related complications, and other cardiovascular risk factors, including non-HDL cholesterol, triglycerides, systolic blood pressure and C-reactive protein
The authors suggested that high dose Wegovy may increase the risk of reduced blood supply to the optic nerve through mechanisms involving blood pressure drops, fluid loss, and instability in the autonomic nervous system
Together, our findings provide new mechanisms for how DA and NE signaling regulates insulin and glucagon release
Half-life & frequency rationale Early intravenous human studies reported a plasma half-life of roughly 15 minutes, with in vitro degradation studies citing a range of about 725 minutes depending on temperature